HoyleCohen, LLC - SUMMIT THERAPEUTICS INC ownership

SUMMIT THERAPEUTICS INC's ticker is SMMT and the CUSIP is 86627T108. A total of 91 filers reported holding SUMMIT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.04 and the average weighting 0.0%.

Quarter-by-quarter ownership
HoyleCohen, LLC ownership history of SUMMIT THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$139,143
-25.5%
74,4080.0%0.01%
-18.8%
Q2 2023$186,765
+43.4%
74,4080.0%0.02%
+33.3%
Q1 2023$130,214
+0.7%
74,408
+144.5%
0.01%
-7.7%
Q4 2022$129,336
+259.3%
30,4320.0%0.01%
+225.0%
Q3 2022$36,000
+20.0%
30,4320.0%0.00%
+33.3%
Q2 2022$30,000
-21.1%
30,432
+97.2%
0.00%0.0%
Q1 2022$38,000
-9.5%
15,4320.0%0.00%0.0%
Q4 2021$42,000
-45.5%
15,4320.0%0.00%
-57.1%
Q3 2021$77,000
-1.3%
15,432
+47.9%
0.01%
+16.7%
Q2 2021$78,000
+27.9%
10,432
+0.7%
0.01%0.0%
Q1 2021$61,000
+24.5%
10,3590.0%0.01%0.0%
Q4 2020$49,00010,3590.01%
Other shareholders
SUMMIT THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Alpine Global Management, LLC 202,928$8620.29%
AWM Investment Company, Inc. 300,000$1,275,0000.18%
Virtus ETF Advisers LLC 42,835$182,0490.10%
Baker Brothers Advisors 2,000,000$8,500,0000.05%
VANCE WEALTH, INC. 13,299$56,5210.04%
Inscription Capital, LLC 17,000$72,2500.02%
Steward Partners Investment Advisory, LLC 305,000$1,296,2500.02%
BOOTHBAY FUND MANAGEMENT, LLC 221,205$940,1210.02%
LEVIN CAPITAL STRATEGIES, L.P. 39,176$166,4980.02%
683 Capital Management, LLC 50,838$216,0620.02%
View complete list of SUMMIT THERAPEUTICS INC shareholders